Association of a low ankle brachial index with progression to end-stage kidney disease in patients with advanced-stage diabetic kidney disease

被引:1
作者
Tang, Ruiying [1 ]
Liu, Yun [2 ]
Chen, Jiexin [1 ]
Deng, Jihong [1 ]
Liu, Yan [2 ]
Xu, Qingdong [1 ]
机构
[1] Jiangmen Cent Hosp, Dept Nephrol, Jiangmen, Peoples R China
[2] Jinan Univ, Guangzhou Red Cross Hosp, Dept Nephrol, Guangzhou, Peoples R China
关键词
Ankle-brachial index; end-stage kidney disease; diabetes; diabetic kidney disease; GLOMERULAR-FILTRATION-RATE; PERIPHERAL ARTERY-DISEASE; MORTALITY; ATHEROSCLEROSIS; MALNUTRITION; INFLAMMATION; SPECTRUM; DECLINE; RISK;
D O I
10.1080/0886022X.2022.2160347
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introductions The effect of a low ankle-brachial index (ABI) in patients with advanced-stage diabetic kidney disease is not fully understood. This study investigates the prevalence of a low ABI in patients with advanced-stage diabetic kidney disease, which was defined as a urinary albumin-to-creatinine ratio (UACR) >= 300 mg/g and an estimated glomerular filtration rate (eGFR) between 15-60 mL/min/1.73 m(2). Furthermore, the association between a low ABI and end-stage kidney disease (ESKD) was determined. Methods This single-center, retrospective, cohort study included 529 patients with advanced-stage diabetic kidney disease who were stratified into groups according to the ABI: high (>1.3), normal (0.9-1.3), and low (<0.9). The Kaplan-Meier method and Cox proportional analysis were used to examine the association between the ABI and ESKD. Results A total of 42.5% of patients with a low ABI progressed to ESKD. A low ABI was associated with a greater risk of ESKD (hazard ratio (HR): 1.073). After adjusting for traditional chronic kidney disease risk factors, a low ABI remained associated with a greater risk of ESKD (HR: 1.758; 95% confidence interval: 1.243-2.487; p = 0.001). Conclusions These results indicate that patients with a low ABI should be monitored carefully. Furthermore, preventive therapy should be considered to improve the long-term kidney survival of patients with residual kidney function.
引用
收藏
页数:8
相关论文
共 50 条
[21]   Cancer Screening in End-Stage Kidney Disease [J].
Shirazian, Shayan ;
Starakiewicz, Piotr ;
Latcha, Sheron .
ADVANCES IN CHRONIC KIDNEY DISEASE, 2021, 28 (05) :502-+
[22]   The Controversies of Coronary Artery Disease in End-Stage Kidney Disease Patients: A Narrative Review [J].
Hirsch, Daniel ;
Lau, Brandon ;
Kushwaha, Virag ;
Yong, Kenneth .
REVIEWS IN CARDIOVASCULAR MEDICINE, 2023, 24 (06)
[23]   End-stage kidney disease patients in the intensive care unit [J].
Bagshaw, Sean M. ;
Uchino, Shigehiko .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (06) :1714-1717
[24]   Association Analysis of the Reticulon 1 Gene in End-Stage Kidney Disease [J].
Bonomo, Jason A. ;
Palmer, Nicholette D. ;
He, John Cijiang ;
Fan, Ying ;
Hicks, Pamela J. ;
Lea, Janice P. ;
Okusa, Mark D. ;
Bowden, Donald W. ;
Freedman, Barry I. .
AMERICAN JOURNAL OF NEPHROLOGY, 2015, 42 (04) :259-264
[25]   Metabolic Surgery to Treat Obesity in Diabetic Kidney Disease, Chronic Kidney Disease, and End-Stage Kidney Disease; What Are the Unanswered Questions? [J].
Martin, William P. ;
White, James ;
Lopez-Hernandez, Francisco J. ;
Docherty, Neil G. ;
le Roux, Carel W. .
FRONTIERS IN ENDOCRINOLOGY, 2020, 11
[26]   The Association of Leptin with Left Ventricular Hypertrophy in End-Stage Kidney Disease Patients on Dialysis [J].
Coimbra, Susana ;
Catarino, Cristina ;
Sameiro Faria, Maria ;
Nunes, Jose Pedro L. ;
Rocha, Susana ;
Valente, Maria Joao ;
Rocha-Pereira, Petronila ;
Bronze-da-Rocha, Elsa ;
Bettencourt, Nuno ;
Beco, Ana ;
Marques, Sofia Homem de Melo ;
Oliveira, Jose Gerardo ;
Madureira, Jose ;
Fernandes, Joao Carlos ;
Miranda, Vasco ;
Belo, Luis ;
Santos-Silva, Alice .
BIOMEDICINES, 2023, 11 (04)
[27]   Outcomes of peripheral artery disease and polyvascular disease in patients with end-stage kidney disease [J].
Mehta, Harsh ;
Chan, Wan-Chi ;
Aday, Aaron W. ;
Jones, W. Schuyler ;
Parmar, Gaurav M. ;
Hance, Kirk ;
Thors, Axel ;
Alli, Adam ;
Wiley, Mark ;
Tadros, Peter ;
Gupta, Kamal .
JOURNAL OF VASCULAR SURGERY, 2024, 79 (05) :1170-1178.e10
[28]   Competing Risk of Death With End-Stage Renal Disease in Diabetic Kidney Disease [J].
Jiang, Yue ;
Fine, Jason P. ;
Mottl, Amy K. .
ADVANCES IN CHRONIC KIDNEY DISEASE, 2018, 25 (02) :133-140
[29]   Is There a Role for SGLT2 Inhibitors in Patients with End-Stage Kidney Disease? [J].
Siddiqui, Rehma ;
Obi, Yoshitsugu ;
Dossabhoy, Neville R. ;
Shafi, Tariq .
CURRENT HYPERTENSION REPORTS, 2024, 26 (12) :463-474
[30]   Urinary uromodulin independently predicts end-stage renal disease and rapid kidney function decline in a cohort of chronic kidney disease patients [J].
Steubl, Dominik ;
Block, Matthias ;
Herbst, Victor ;
Nockher, Wolfgang Andreas ;
Schlumberger, Wolfgang ;
Kemmner, Stephan ;
Bachmann, Quirin ;
Angermann, Susanne ;
Wen, Ming ;
Heemann, Uwe ;
Renders, Lutz ;
Garimella, Pranav S. ;
Scherberich, Juergen .
MEDICINE, 2019, 98 (21)